A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major

NCT06065189 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Long-term Follow-up Study of BHC001 for TDT

NCT06314529 ·Status: RECRUITING

Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.

NCT06655662 ·Status: RECRUITING ·Phase: PHASE1

Long-term Follow-up Study of BRL-101 for TDT

NCT06298630 ·Status: NOT_YET_RECRUITING

A Long-term Follow-up Study in Participants Who Received CTX001

NCT04208529 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

NCT04390971 ·Status: COMPLETED ·Phase: NA

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

NCT05015920 ·Status: COMPLETED ·Phase: NA

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

NCT05860595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

NCT05745532 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

NCT00171171 ·Status: COMPLETED ·Phase: PHASE3

β-globin Restored Autologous HSC in β-thalassemia Major Patients

NCT04205435 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

NCT00171301 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells

NCT06041620 ·Status: RECRUITING ·Phase: NA

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

NCT01571635 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

NCT06219239 ·Status: RECRUITING ·Phase: NA

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

NCT05762510 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

NCT06164821 ·Status: RECRUITING ·Phase: NA

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00000595 ·Status: COMPLETED ·Phase: PHASE2

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

NCT05355766 ·Status: COMPLETED ·Phase: PHASE2

CS-206 in Patients With Sickle Cell Disease

NCT06565026 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector

NCT03351829 ·Status: UNKNOWN ·Phase: NA

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

NCT05851105 ·Status: RECRUITING ·Phase: EARLY_PHASE1

A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia

NCT03655678 ·Status: COMPLETED ·Phase: PHASE2/PHASE3